These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20592045)

  • 21. New ESMO scale ranks mutations as cancer medicine targets.
    Fricker J
    Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495
    [No Abstract]   [Full Text] [Related]  

  • 22. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
    Covell DG
    PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New frontiers in therapeutic resistance in cancer.
    Sartore-Bianchi A; Delorenzi M; Gagnon-Kugler T; Rousseau C; Batist G
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):877-9. PubMed ID: 22845402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L; Lind MJ; Welham KJ; Cawkwell L;
    Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
    Scholler N
    IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
    [No Abstract]   [Full Text] [Related]  

  • 26. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 27. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational prediction of cancer-gene function.
    Hu P; Bader G; Wigle DA; Emili A
    Nat Rev Cancer; 2007 Jan; 7(1):23-34. PubMed ID: 17167517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine.
    Tsimberidou AM
    Curr Probl Cancer; 2017; 41(3):176-181. PubMed ID: 28410846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Male infertility biomarkers and genomic aberrations in azoospermia.
    Kovac JR; Lamb DJ
    Fertil Steril; 2014 May; 101(5):e31. PubMed ID: 24680367
    [No Abstract]   [Full Text] [Related]  

  • 31. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New findings offer insight into resistance to breast cancer therapy.
    Womens Health (Lond); 2010 Jul; 6(4):493. PubMed ID: 20597624
    [No Abstract]   [Full Text] [Related]  

  • 33. Proteomics for identifying mechanisms and biomarkers of drug resistance in cancer.
    Li XH; Li C; Xiao ZQ
    J Proteomics; 2011 Nov; 74(12):2642-9. PubMed ID: 21964283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel biomarkers in cancer: The whole is greater than the sum of its parts.
    Samatov TR; Galatenko VV; Block A; Shkurnikov MY; Tonevitsky AG; Schumacher U
    Semin Cancer Biol; 2017 Aug; 45():50-57. PubMed ID: 27639751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer drug discovery using chemical genomics.
    Sehgal A
    Curr Med Chem; 2003 May; 10(9):749-55. PubMed ID: 12678778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large-scale profiling of microRNAs for The Cancer Genome Atlas.
    Chu A; Robertson G; Brooks D; Mungall AJ; Birol I; Coope R; Ma Y; Jones S; Marra MA
    Nucleic Acids Res; 2016 Jan; 44(1):e3. PubMed ID: 26271990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers.
    Ow TJ; Sandulache VC; Skinner HD; Myers JN
    Cancer; 2013 Nov; 119(22):3914-28. PubMed ID: 24037788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges in molecular analysis for individualized cancer therapy.
    Clynes M; O'Connor R; O'Driscoll L; Daly C; Meleady P
    Drug Discov Today; 2003 Jun; 8(12):531. PubMed ID: 12821298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.